ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syr...
FDA Recall #D-0141-2024 — Class II — November 22, 2023
Product Description
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Reason for Recall
Lack of assurance of sterility.
Recalling Firm
Wells Pharma of Houston LLC — Houston, TX
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
825 syringes
Distribution
Philadelphia, Pennsylvania.
Code Information
Lot # 11092313110#01, Exp 01/12/24
Status
Completed
Voluntary / Mandated
Voluntary: Firm initiated